UnitedHealth Group Incorporated $UNH Stock Position Trimmed by Geneos Wealth Management Inc.

Key Points

• Geneos Wealth Management Inc. reduced its stake in UnitedHealth Group by 39.5% during the first quarter, owning 8,272 shares after selling 5,412 shares.
• Analyst ratings for UnitedHealth are mixed, with 16 analysts rating it as "Buy", 6 as "Hold", and 3 as "Sell", and an average price target of $355.77.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, yielding 2.5% annually, with a payout ratio of 38.30%.

Geneos Wealth Management Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,272 shares of the healthcare conglomerate's stock after selling 5,412 shares during the quarter. Geneos Wealth Management Inc.'s holdings in UnitedHealth Group were worth $4,332,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Citizens National Bank Trust Department raised its position in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after buying an additional 1,465 shares in the last quarter. Caitlin John LLC raised its position in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after buying an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $515,000. Finally, Silvercrest Asset Management Group LLC raised its position in shares of UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after buying an additional 12,550 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the stock. Deutsche Bank Aktiengesellschaft dropped their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $355.77.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $347.27 on Thursday. The firm's 50 day simple moving average is $290.20 and its 200-day simple moving average is $371.22. The company has a market cap of $314.51 billion, a P/E ratio of 15.05, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.